Comparison of tepoxalin, carprofen, and meloxicam for reducing intraocular inflammation in dogs

Margi A. Gilmour, Terry W Lehenbauer

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective - To compare effects of orally administered tepoxalin, carprofen, and meloxicam for controlling aqueocentesis-induced anterior uveitis in dogs, as determined by measurement of aqueous prostaglandin E2 (PGE 2) concentrations. Animals - 38 mixed-breed dogs. Procedures - Dogs were allotted to a control group and 3 treatment groups. Dogs in the control group received no medication. Dogs in each of the treatment groups received an NSAID (tepoxalin, 10 mg/kg, PO, q 24 h; carprofen, 2.2 mg/kg, PO, q 12 h; or meloxicam, 0.2 mg/kg, PO, q 24 h) on days 0 and 1. On day 1, dogs were anesthetized and an initial aqueocentesis was performed on both eyes; 1 hour later, a second aqueocentesis was performed. Aqueous samples were frozen at -80°C until assayed for PGE2 concentrations via an enzyme immunoassay kit. Results - Significant differences between aqueous PGE 2 concentrations in the first and second samples from the control group indicated that aqueocentesis induced uveitis. Median change in PGE 2 concentrations for the tepoxalin group (10 dogs [16 eyes]) was significantly lower than the median change for the control group (8 dogs [16 eyes]), carprofen group (9 dogs [16 eyes]), or meloxicam group (9 dogs [16 eyes]). Median changes in PGE2 concentrations for dogs treated with meloxicam or carprofen were lower but not significantly different from changes for control dogs. Conclusions and Clinical Relevance - Tepoxalin was more effective than carprofen or meloxicam for controlling the production of PGE 2 in dogs with experimentally induced uveitis. Tepoxalin may be an appropriate choice when treating dogs with anterior uveitis.

Original languageEnglish (US)
Pages (from-to)902-907
Number of pages6
JournalAmerican Journal of Veterinary Research
Volume70
Issue number7
DOIs
StatePublished - Jul 2009

Fingerprint

meloxicam
inflammation
Dogs
Inflammation
dogs
Dinoprostone
eyes
prostaglandins
Anterior Uveitis
Control Groups
Uveitis
carprofen
tepoxalin

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Comparison of tepoxalin, carprofen, and meloxicam for reducing intraocular inflammation in dogs. / Gilmour, Margi A.; Lehenbauer, Terry W.

In: American Journal of Veterinary Research, Vol. 70, No. 7, 07.2009, p. 902-907.

Research output: Contribution to journalArticle

@article{2556a6b399f24b5c9a501f5c5581f86f,
title = "Comparison of tepoxalin, carprofen, and meloxicam for reducing intraocular inflammation in dogs",
abstract = "Objective - To compare effects of orally administered tepoxalin, carprofen, and meloxicam for controlling aqueocentesis-induced anterior uveitis in dogs, as determined by measurement of aqueous prostaglandin E2 (PGE 2) concentrations. Animals - 38 mixed-breed dogs. Procedures - Dogs were allotted to a control group and 3 treatment groups. Dogs in the control group received no medication. Dogs in each of the treatment groups received an NSAID (tepoxalin, 10 mg/kg, PO, q 24 h; carprofen, 2.2 mg/kg, PO, q 12 h; or meloxicam, 0.2 mg/kg, PO, q 24 h) on days 0 and 1. On day 1, dogs were anesthetized and an initial aqueocentesis was performed on both eyes; 1 hour later, a second aqueocentesis was performed. Aqueous samples were frozen at -80°C until assayed for PGE2 concentrations via an enzyme immunoassay kit. Results - Significant differences between aqueous PGE 2 concentrations in the first and second samples from the control group indicated that aqueocentesis induced uveitis. Median change in PGE 2 concentrations for the tepoxalin group (10 dogs [16 eyes]) was significantly lower than the median change for the control group (8 dogs [16 eyes]), carprofen group (9 dogs [16 eyes]), or meloxicam group (9 dogs [16 eyes]). Median changes in PGE2 concentrations for dogs treated with meloxicam or carprofen were lower but not significantly different from changes for control dogs. Conclusions and Clinical Relevance - Tepoxalin was more effective than carprofen or meloxicam for controlling the production of PGE 2 in dogs with experimentally induced uveitis. Tepoxalin may be an appropriate choice when treating dogs with anterior uveitis.",
author = "Gilmour, {Margi A.} and Lehenbauer, {Terry W}",
year = "2009",
month = "7",
doi = "10.2460/ajvr.70.7.902",
language = "English (US)",
volume = "70",
pages = "902--907",
journal = "American Journal of Veterinary Research",
issn = "0002-9645",
publisher = "American Veterinary Medical Association",
number = "7",

}

TY - JOUR

T1 - Comparison of tepoxalin, carprofen, and meloxicam for reducing intraocular inflammation in dogs

AU - Gilmour, Margi A.

AU - Lehenbauer, Terry W

PY - 2009/7

Y1 - 2009/7

N2 - Objective - To compare effects of orally administered tepoxalin, carprofen, and meloxicam for controlling aqueocentesis-induced anterior uveitis in dogs, as determined by measurement of aqueous prostaglandin E2 (PGE 2) concentrations. Animals - 38 mixed-breed dogs. Procedures - Dogs were allotted to a control group and 3 treatment groups. Dogs in the control group received no medication. Dogs in each of the treatment groups received an NSAID (tepoxalin, 10 mg/kg, PO, q 24 h; carprofen, 2.2 mg/kg, PO, q 12 h; or meloxicam, 0.2 mg/kg, PO, q 24 h) on days 0 and 1. On day 1, dogs were anesthetized and an initial aqueocentesis was performed on both eyes; 1 hour later, a second aqueocentesis was performed. Aqueous samples were frozen at -80°C until assayed for PGE2 concentrations via an enzyme immunoassay kit. Results - Significant differences between aqueous PGE 2 concentrations in the first and second samples from the control group indicated that aqueocentesis induced uveitis. Median change in PGE 2 concentrations for the tepoxalin group (10 dogs [16 eyes]) was significantly lower than the median change for the control group (8 dogs [16 eyes]), carprofen group (9 dogs [16 eyes]), or meloxicam group (9 dogs [16 eyes]). Median changes in PGE2 concentrations for dogs treated with meloxicam or carprofen were lower but not significantly different from changes for control dogs. Conclusions and Clinical Relevance - Tepoxalin was more effective than carprofen or meloxicam for controlling the production of PGE 2 in dogs with experimentally induced uveitis. Tepoxalin may be an appropriate choice when treating dogs with anterior uveitis.

AB - Objective - To compare effects of orally administered tepoxalin, carprofen, and meloxicam for controlling aqueocentesis-induced anterior uveitis in dogs, as determined by measurement of aqueous prostaglandin E2 (PGE 2) concentrations. Animals - 38 mixed-breed dogs. Procedures - Dogs were allotted to a control group and 3 treatment groups. Dogs in the control group received no medication. Dogs in each of the treatment groups received an NSAID (tepoxalin, 10 mg/kg, PO, q 24 h; carprofen, 2.2 mg/kg, PO, q 12 h; or meloxicam, 0.2 mg/kg, PO, q 24 h) on days 0 and 1. On day 1, dogs were anesthetized and an initial aqueocentesis was performed on both eyes; 1 hour later, a second aqueocentesis was performed. Aqueous samples were frozen at -80°C until assayed for PGE2 concentrations via an enzyme immunoassay kit. Results - Significant differences between aqueous PGE 2 concentrations in the first and second samples from the control group indicated that aqueocentesis induced uveitis. Median change in PGE 2 concentrations for the tepoxalin group (10 dogs [16 eyes]) was significantly lower than the median change for the control group (8 dogs [16 eyes]), carprofen group (9 dogs [16 eyes]), or meloxicam group (9 dogs [16 eyes]). Median changes in PGE2 concentrations for dogs treated with meloxicam or carprofen were lower but not significantly different from changes for control dogs. Conclusions and Clinical Relevance - Tepoxalin was more effective than carprofen or meloxicam for controlling the production of PGE 2 in dogs with experimentally induced uveitis. Tepoxalin may be an appropriate choice when treating dogs with anterior uveitis.

UR - http://www.scopus.com/inward/record.url?scp=67651238508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651238508&partnerID=8YFLogxK

U2 - 10.2460/ajvr.70.7.902

DO - 10.2460/ajvr.70.7.902

M3 - Article

VL - 70

SP - 902

EP - 907

JO - American Journal of Veterinary Research

JF - American Journal of Veterinary Research

SN - 0002-9645

IS - 7

ER -